PP
MRK icon

PFS Partners’s Merck MRK Stock Holding History

PFS Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Sell
4,033
-32
-0.8% -$3.75K 0.21% 52
2026
Q1 		$489K Sell
4,065
-42
-1% -$4.85K 0.22% 45
2025
Q4 		$432K Buy
4,107
+34
+0.8% +$3.19K 0.2% 46
2025
Q3 		$342K Buy
4,073
+373
+10% +$30.7K 0.16% 51
2025
Q2 		$293K Buy
3,700
+36
+1% +$2.86K 0.15% 53
2025
Q1 		$329K Buy
3,664
+29
+0.8% +$2.71K 0.17% 49
2024
Q4 		$362K Sell
3,635
-28
-0.8% -$2.89K 0.19% 44
2024
Q3 		$416K Buy
3,663
+22
+0.6% +$2.61K 0.24% 38
2024
Q2 		$451K Buy
3,641
+9
+0.2% +$1.16K 0.28% 34
2024
Q1 		$479K Buy
3,632
+17
+0.5% +$2.1K 0.32% 32
2023
Q4 		$394K Buy
3,615
+437
+14% +$45.4K 0.27% 33
2023
Q3 		$327K Buy
3,178
+19
+0.6% +$2.05K 0.29% 26
2023
Q2 		$365K Buy
3,159
+19
+0.6% +$2.16K 0.31% 24
2023
Q1 		$334K Buy
3,140
+93
+3% +$10K 0.33% 25
2022
Q4 		$338K Buy
3,047
+22
+0.7% +$2.25K 0.36% 24
2022
Q3 		$261K Buy
3,025
+90
+3% +$8.03K 0.28% 28
2022
Q2 		$268K Buy
2,935
+22
+0.8% +$1.95K 0.26% 29
2022
Q1 		$239K Buy
2,913
+22
+0.8% +$1.74K 0.21% 34
2021
Q4 		$222K Buy
+2,891
New +$230K 0.16% 35

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PFS Partners's MRK Position: Q2 2026 in Review

PFS Partners reduced its Merck (MRK) stake by 0.79% in Q2 2026, selling an estimated $3.75K and leaving 4,033 shares worth $518K. The position accounts for 0.21% of the portfolio, ranked #52.

PFS Partners first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • PFS Partners held 4,033 shares of Merck worth $518K as of Q2 2026.
  • PFS Partners sold 32 Merck shares in Q2 2026, an estimated $3.75K.
  • Merck made up 0.21% of PFS Partners's portfolio in Q2 2026, its #52 holding.
  • PFS Partners first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.